Advertisement
Advertisement

IFRX

IFRX logo

InflaRx N.V. Common Stock

1.89
USD
Sponsored
-0.04
-2.33%
Jun 25, 15:45 UTC -4
Open

IFRX Earnings Reports

Positive Surprise Ratio

IFRX beat 22 of 35 last estimates.

63%

Next Report

Date of Next Report
Aug 05, 2026
Estimate for Q2 26 (Revenue/ EPS)
$3.57K
/
-$0.08
Implied change from Q1 26 (Revenue/ EPS)
--
/
--
Implied change from Q2 25 (Revenue/ EPS)
-90.85%
/
-61.90%

InflaRx N.V. Common Stock earnings per share and revenue

On May 06, 2026, IFRX reported earnings of -0.08 USD per share (EPS) for Q1 26, beating the estimate of -0.12 USD, resulting in a 33.72% surprise. Revenue reached --, compared to an expected 4.93 thousand, with a -100.00% difference. The market reacted with a +6.00% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 6 analysts forecast an EPS of -0.08 USD, with revenue projected to reach 3.57 thousand USD, implying an increase of 0.00% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
enGene Therapeutics Inc. Common Stock
Report Date
Jun 15, 2026 For Q2 26
Estimate
-$0.47
Actual
-$0.43
Surprise
+10.32%
logo
Grace Therapeutics, Inc. Common Stock
Report Date
Jun 18, 2026 For Q4 26
Estimate
-$0.23
Actual
-$0.06
Surprise
+74.42%
logo
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
FAQ
For Q1 2026, InflaRx N.V. Common Stock reported EPS of -$0.08, beating estimates by 33.72%, and revenue of $0.00, -100% below expectations.
The stock price moved up 6%, changed from $2.50 before the earnings release to $2.65 the day after.
The next earning report is scheduled for Aug 05, 2026.
Based on 6 analysts, InflaRx N.V. Common Stock is expected to report EPS of -$0.08 and revenue of $3.57K for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement